SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $28.06MP/E –Yield –
Scynexis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Scynexis's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.31M. For fiscal 2025 it was -$5.28M. The highest annual figure on record is $60.16M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.28M | – |
| FY2024 | Dec 31, 2024 | -$24.01M | -139.9% |
| FY2023 | Dec 31, 2023 | $60.16M | – |
| FY2022 | Dec 31, 2022 | -$79.88M | – |
| FY2021 | Dec 31, 2021 | -$54.56M | – |
| FY2020 | Dec 31, 2020 | -$49.35M | – |
| FY2019 | Dec 31, 2019 | -$38.12M | – |
| FY2018 | Dec 31, 2018 | -$28.32M | – |
| FY2017 | Dec 31, 2017 | -$24.56M | – |
| FY2016 | Dec 31, 2016 | -$29.35M | – |
| FY2015 | Dec 31, 2015 | -$24.55M | – |
| FY2014 | Dec 31, 2014 | -$9.47M | – |
| FY2013 | Dec 31, 2013 | -$4.31M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.89M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.10M | – |
| Q4 FY2025 | Dec 31, 2025 | $18.40M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.72M | -1240.4% |
| Q2 FY2025 | Jun 30, 2025 | -$7.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.91M | – |
| Q3 FY2024 | Sep 30, 2024 | $765.00K | -93.8% |
| Q2 FY2024 | Jun 30, 2024 | -$10.86M | -114.6% |
| Q1 FY2024 | Mar 31, 2024 | -$4.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.74M | – |
| Q3 FY2023 | Sep 30, 2023 | $12.42M | – |
| Q2 FY2023 | Jun 30, 2023 | $74.40M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.92M | – |
| Q4 FY2022 | Dec 31, 2022 | -$22.81M | – |
| Q3 FY2022 | Sep 30, 2022 | -$22.51M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.99M | – |
| Q4 FY2021 | Dec 31, 2021 | -$25.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$16.59M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.70M | – |
| Q1 FY2021 | Mar 31, 2021 | -$759.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.57M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.87M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.86M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.46M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.40M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.76M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.50M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.06M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.15M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.90M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.22M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.16M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.38M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.77M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.55M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.85M | – |
See a number that looks wrong?